Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Instil Bio, Inc. (NQ:TIL)

29.65 +2.70 (+10.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,221,703
Open 35.14
Bid (Size) 30.38 (2)
Ask (Size) 30.70 (1)
Prev. Close 26.95
Today's Range 29.30 - 38.25
52wk Range 9.620 - 92.00
Shares Outstanding 3,290,884
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill

Performance

YTD
+37.1%
+37.1%
1 Month
+138.3%
+138.3%
3 Month
+46.6%
+46.6%
6 Month
+13.3%
+13.3%
1 Year
+170.5%
+170.5%

More News

Read More
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
From Instil Bio
Via GlobeNewswire
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
From Instil Bio
Via GlobeNewswire
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
From Instil Bio
Via GlobeNewswire
Keep an eye on the top gainers and losers in Thursday's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated
From Instil Bio
Via GlobeNewswire
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
From Instil Bio
Via GlobeNewswire
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Via Benzinga
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Instil Bio
Via GlobeNewswire
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
Via The Motley Fool
Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Instil Bio, Inc. publicly traded?
Yes, Instil Bio, Inc. is publicly traded.
What exchange does Instil Bio, Inc. trade on?
Instil Bio, Inc. trades on the Nasdaq Stock Market
What is the ticker symbol for Instil Bio, Inc.?
The ticker symbol for Instil Bio, Inc. is TIL on the Nasdaq Stock Market
What is the current price of Instil Bio, Inc.?
The current price of Instil Bio, Inc. is 29.65
When was Instil Bio, Inc. last traded?
The last trade of Instil Bio, Inc. was at 06/02/25 04:00 PM ET
What is the market capitalization of Instil Bio, Inc.?
The market capitalization of Instil Bio, Inc. is 97.57M
How many shares of Instil Bio, Inc. are outstanding?
Instil Bio, Inc. has 98M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.